Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Leukemia

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 34 articles: HTML format

Single Articles

July 2024
1. SCHNEIDER C, Spaink H, Alexe G, Dharia NV, et al
   Targeting the Sodium-Potassium Pump as a Therapeutic Strategy in Acute Myeloid Leukemia.
   Cancer Res. 2024 Jul 18. doi: 10.1158/0008-5472.CAN-23-3560.
   PubMed     Abstract available
   
   
   June 2024
2. POORT VM, Hagelaar R, van Roosmalen MJ, Trabut L, et al
   Transient Differentiation-State Plasticity Occurs During Acute Lymphoblastic Leukemia Initiation.
   Cancer Res. 2024 Jun 17. doi: 10.1158/0008-5472.CAN-24-1090.
   PubMed     Abstract available
   
   
   
3. BERTOLI RM, Chung YJ, Difilippantonio MJ, Wokasch A, et al
   The DNA methyltransferase inhibitor 5-aza-4'-thio-2'-deoxycytidine induces C>G transversions and acute lymphoid leukemia development.
   Cancer Res. 2024 Jun 4. doi: 10.1158/0008-5472.CAN-23-2785.
   PubMed     Abstract available
   
   
   April 2024
4. BOET E, Sarry JE
   Targeting Metabolic Dependencies Fueling the TCA Cycle to Circumvent Therapy Resistance in Acute Myeloid Leukemia.
   Cancer Res. 2024;84:950-952.
   PubMed     Abstract available
   
   
   February 2024
5. JIN P, Wang X, Jin Q, Zhang Y, et al
   Mutant U2AF1-induced mis-splicing of mRNA translation genes confers resistance to chemotherapy in acute myeloid leukemia.
   Cancer Res. 2024 Feb 28. doi: 10.1158/0008-5472.CAN-23-2543.
   PubMed     Abstract available
   
   
   
6. LIU ZS, Sinha S, Bannister M, Song A, et al
   R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription-Replication Conflicts.
   Cancer Res. 2024;84:577-597.
   PubMed     Abstract available
   
   
   January 2024
7. MONTEITH AJ, Ramsey HE, Silver AJ, Brown D, et al
   Lactate utilization enables metabolic escape to confer resistance to BET inhibition in acute myeloid leukemia.
   Cancer Res. 2024 Jan 29. doi: 10.1158/0008-5472.CAN-23-0291.
   PubMed     Abstract available
   
   
   
8. SU Y, Carter JL, Li X, Fukuda Y, et al
   The imipridone ONC213 targets alpha-ketoglutarate dehydrogenase to induce mitochondrial stress and suppress oxidative phosphorylation in acute myeloid leukemia.
   Cancer Res. 2024 Jan 24. doi: 10.1158/0008-5472.CAN-23-2659.
   PubMed     Abstract available
   
   
   
9. RAUCCI F, Vernieri C, Di Tano M, Ligorio F, et al
   Cyclic fasting-mimicking diet plus bortezomib and rituximab is an effective treatment for chronic lymphocytic leukemia.
   Cancer Res. 2024 Jan 19. doi: 10.1158/0008-5472.CAN-23-0295.
   PubMed     Abstract available
   
   
   
10. WANG P, Zhang Y, Xiang R, Yang J, et al
    Foretinib is effective in acute myeloid leukemia by inhibiting FLT3 and overcoming secondary mutations that drive resistance to quizartinib and gilteritinib.
    Cancer Res. 2024 Jan 17. doi: 10.1158/0008-5472.CAN-23-1534.
    PubMed     Abstract available
    
    
    December 2023
11. MAI S, Hodges A, Chen HM, Zhang J, et al
    LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.
    Cancer Res. 2023;83:4047-4062.
    PubMed     Abstract available
    
    
    
12. XIA L, Liu JY, Yang MY, Zhang XH, et al
    Osimertinib covalently binds to CD34 and eliminates myeloid leukemia stem/progenitor cells.
    Cancer Res. 2023 Dec 14. doi: 10.1158/0008-5472.CAN-23-1632.
    PubMed     Abstract available
    
    
    October 2023
13. MODI A, Lopez G, Conkrite KL, Su C, et al
    Integrative Genomic Analyses Identify LncRNA Regulatory Networks across Pediatric Leukemias and Solid Tumors.
    Cancer Res. 2023;83:3462-3477.
    PubMed     Abstract available
    
    
    September 2023
14. ZIERHUT C
    p53 and Innate Immune Signaling in Development and Cancer: Insights from a Hematologic Model of Genome Instability.
    Cancer Res. 2023;83:2807-2808.
    PubMed     Abstract available
    
    
    
15. DRESSEL N, Natusch L, Munz CM, Costas Ramon S, et al
    Activation of the cGAS/STING Axis in Genome-Damaged Hematopoietic Cells Does Not Impact Blood Cell Formation or Leukemogenesis.
    Cancer Res. 2023;83:2858-2872.
    PubMed     Abstract available
    
    
    August 2023
16. JONES CL
    Turning Down the Temperature on Leukemia Stem Cells.
    Cancer Res. 2023;83:2441-2442.
    PubMed     Abstract available
    
    
    June 2023
17. FARGE T, Nakhle J, Lagarde D, Cognet G, et al
    CD36 drives metastasis and relapse in acute myeloid leukemia.
    Cancer Res. 2023 Jun 16:CAN-22-3682. doi: 10.1158/0008-5472.CAN-22-3682.
    PubMed     Abstract available
    
    
    
18. GRIESSINGER E, Pereira-Martins D, Nebout M, Bosc C, et al
    Oxidative phosphorylation fueled by fatty acid oxidation sensitizes leukemic stem cells to cold.
    Cancer Res. 2023 Jun 5:CAN-23-1006. doi: 10.1158/0008-5472.CAN-23-1006.
    PubMed     Abstract available
    
    
    May 2023
19. SEKHAR KR, Freeman ML
    Nucleophosmin Plays a Role in Repairing DNA Damage and Is a Target for Cancer Treatment.
    Cancer Res. 2023;83:1573-1580.
    PubMed     Abstract available
    
    
    January 2023
20. CHAMBERS C, Cermakova K, Chan YS, Kurtz K, et al
    SWI/SNF blockade disrupts PU.1-directed enhancer programs in normal hematopoietic cells and acute myeloid leukemia.
    Cancer Res. 2023 Jan 20:CAN-22-2129. doi: 10.1158/0008-5472.CAN-22-2129.
    PubMed     Abstract available
    
    
    
21. HONG YG, Yang Z, Chen Y, Liu T, et al
    The RNA m6A reader YTHDF1 is required for acute myeloid leukemia progression.
    Cancer Res. 2023 Jan 12:CAN-21-4249. doi: 10.1158/0008-5472.CAN-21-4249.
    PubMed     Abstract available
    
    
    November 2022
22. ZHU LY, Yuan JB, Zhang L, He CX, et al
    Loss of MLL Induces Epigenetic Dysregulation of Rasgrf1 to Attenuate Kras-Driven Lung Tumorigenesis.
    Cancer Res. 2022;82:4153-4163.
    PubMed     Abstract available
    
    
    September 2022
23. LIU ACH, Cathelin S, Yang Y, Dai DL, et al
    Targeting STAT5 signaling overcomes resistance to IDH inhibitors in acute myeloid leukemia through suppression of stemness.
    Cancer Res. 2022 Sep 23. pii: 709375. doi: 10.1158/0008-5472.CAN-22-1293.
    PubMed     Abstract available
    
    
    August 2022
24. HNATIUK AP, Bruyneel AAN, Tailor D, Pandrala M, et al
    Reengineering Ponatinib to Minimize Cardiovascular Toxicity.
    Cancer Res. 2022;82:2777-2791.
    PubMed     Abstract available
    
    
    June 2022
25. PFEIFFER A, Franciosa G, Locard-Paulet M, Piga I, et al
    Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD-Driven AML.
    Cancer Res. 2022;82:2141-2155.
    PubMed     Abstract available
    
    
    March 2022
26. CASADO-GARCIA A, Isidro-Hernandez M, Oak N, Mayado A, et al
    Transient Inhibition of the JAK/STAT Pathway Prevents B-ALL Development in Genetically Predisposed Mice.
    Cancer Res. 2022;82:1098-1109.
    PubMed     Abstract available
    
    
    
27. BRAUN T, Stachelscheid J, Bley N, Oberbeck S, et al
    Non-canonical function of AGO2 augments T-cell receptor signaling in T-cell prolymphocytic leukemia.
    Cancer Res. 2022 Mar 8. pii: 682091. doi: 10.1158/0008-5472.CAN-21-1908.
    PubMed     Abstract available
    
    
    December 2021
28. PORAZZI P, Petruk S, Pagliaroli L, De Dominici M, et al
    Targeting chemotherapy to de-condensed H3K27me3-marked chromatin of AML cells enhances leukemia suppression.
    Cancer Res. 2021 Dec 13. pii: 0008-5472.CAN-21-1297.
    PubMed     Abstract available
    
    
    October 2021
29. BIRAN A, Yin S, Kretzmer H, Ten Hacken E, et al
    Activation of Notch and Myc signaling via B cell-restricted depletion of Dnmt3a generates a consistent murine model of chronic lymphocytic leukemia.
    Cancer Res. 2021 Oct 22. pii: 0008-5472.CAN-21-1273.
    PubMed     Abstract available
    
    
    
30. GOLDBERG L, Negi V, Chung YJ, Onozawa M, et al
    Mutant Idh2 Cooperates with a NUP98-HOXD13 Fusion to Induce Early Immature Thymocyte Precursor ALL.
    Cancer Res. 2021;81:5033-5046.
    PubMed     Abstract available
    
    
    September 2021
31. SANJIV K, Calderon-Montano JM, Pham TM, Erkers T, et al
    MTH1 inhibitor TH1579 induces oxidative DNA damage and mitotic arrest in acute myeloid leukemia.
    Cancer Res. 2021 Sep 30. pii: 0008-5472.CAN-21-0061.
    PubMed     Abstract available
    
    
    July 2021
32. MAIFREDE S, Le BV, Nieborowska-Skorska M, Golovine K, et al
    TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors.
    Cancer Res. 2021 Jul 2. pii: 0008-5472.CAN-20-3761.
    PubMed     Abstract available
    
    
    February 2021
33. O'HAGAN HM, Rassool FV, Nephew KP
    How Epigenetic Therapy Beats Adverse Genetics in Monosomy Karyotype AML.
    Cancer Res. 2021;81:813-815.
    PubMed     Abstract available
    
    
    
34. GREVE G, Schuler J, Gruning BA, Berberich B, et al
    Decitabine Induces Gene Derepression on Monosomic Chromosomes: In Vitro and In Vivo Effects in Adverse-Risk Cytogenetics AML.
    Cancer Res. 2021;81:834-846.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.